Nuclera
Nuclera mission is to accelerate discovery by providing researchers rapid, easy access to the highest-quality functional proteins essential for drug discovery research. Our eProtein Discovery™ benchtop system combines unique cell-free expression systems, novel digital microfluidics, and robust screening data to empower scientists to perform multiplex protein screening, characterization, and small-scale expression in-house
By providing clear guidance on which protein has the best chance of success from the start, eProtein Discovery™ reduces the time, cost, and uncertainty traditionally associated with protein expression and purification. Researchers can generate soluble, purified proteins, including challenging membrane proteins, for downstream functional testing in under 48 hours, significantly accelerating workflows compared with months-long cell-based methods.
Founded in 2013 by PhD students at the University of Cambridge, Nuclera has expanded its presence to Cambridge, UK, and Boston, MA. With a team of over 100 employees, we remain dedicated to our vision of making proteins easily accessible and contributing to advancements in human health.